Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7582733 Humanized antibodies that recognize beta amyloid peptide

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jose William Saldanha0

Guriq Basi0

Date of Patent

September 1, 2009

0

Patent Application Number

102320300

Date Filed

August 30, 2002

0

Patent Citations Received

US Patent 12071472 Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers

0

US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide

US Patent 11905318 Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

0

US Patent 11970522 Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

0

Patent Primary Examiner

0

Patent abstract

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7582733 Humanized antibodies that recognize beta amyloid peptide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool